AMENDMENT TO MARKETING AUTHORIZATION HOLDER AGREEMENT (“Amendment 3”)Marketing Authorization Holder Agreement • July 28th, 2017 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 28th, 2017 Company IndustryThis Amendment (“Amendment 3”) is made this July 7th, 2017, by and between Oxford Immunotec Limited, a company organized and existing under the laws of UK, address at 94C Innovation Drive Milton Park, Abingdon, Oxfordshire OX14 4RZ United Kingdom (hereinafter referred to as "MANUFACTURER", and RIKEN GENESIS CO., LTD., a company organized and existing under the laws of Japan, address at Art Village Osaki Central Tower 8F, 1-2-2 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan (hereinafter referred to as “MAH”).